In the News

Oncode researchers are featured regularly in the (national) media. This shows that their hard work goes beyond the interest of the Oncology community. We are proud of how our Oncode researchers explain their science to the general public. On this page we share the highlights of their media appearances.

16 - 03 - 2021

Cells that can cry 

De Volkskrant publishes a column on Hans Clevers and his colleagues’ at the Hubrecht Institute research into the human lacrimal gland using organoids and single-cell sequencing, and how the researchers were able to make the lab-made tear glands ‘cry’. 

4 - 03 - 2021

Crowning achievement 

Lude Franke (UMCG) receives 1.5 million euros in Vici funding by the NWO! Franke will further develop his research into gene networks and investigate whether germline and somatic mutations which cause diseases - including cancer - share common principles. 

24 - 9 - 2020

Surprise visits 

This year, the presentation ceremony for the Spinoza and Stevin prizes took place in another form: NWO paid a surprise visit to Spinozalaureaat Sjaak Neefjes (LUMC) and and StevinLaureaat Ton Schumacher (NKI), to hand them their bronze Spinoza statue and the accompanying certificate.  

28 - 1 - 2021

‘’The beast’’: a science innovation with major impact 

Wouter de Laat (Hubrecht Institute) was invited to the BNR news radio show to talk about ‘’the beast’’: the unique COVID-19 test robot co-invented by himself and Marvin Tanenbaum (Hubrecht Institute). The robot is capable of processing 20.000 qPCR-test per 24 hours.  

22 - 1 - 2020

A roadmap that shows how our genes allow cells to function 

Thijn Brummelkamp (NKI) is interviewed by NWO about his Vici research creating a roadmap for how the human cell works. With his earlier developed technique for switching genes on and off on a large scale, he works now on a roadmap that might facilitate the development of new drugs against genetic disorders and cancer.


15-12 -2020

Five more years of healthy life through collaboration 

The LSH update from Health Holland publishes an interview with Oncode former general director Ton Rijnders. Ton explains how collaboration is the fundamental idea behind Oncode is collaboration, as that the competition model does not work well for finding new breakthroughs in cancer research. He also talks about the three means to achieve the goal of having five more years of healthy life by 2040 – which is part of the central mission of the Mission-Driven Top Sectors and Innovation Policy. 

3 - 12- 2020

The wings of science 

SUN columnist and stage 4 bowel cancer patient Deborah James thanked Rene Bernards (NKI)on the British television show Lorraine, for her research that helped save her life. Rene Bernards led the drugs trial which Deborah has been a part of.


26 - 1 - 2020

A prize-winning technology-based approach 

Ton Schumacher (NKI) wins the renowned Jeantet-Collen Prize for Translational Medicine! This award comes in recognition of his work developing technologies to study the role of the immune system in cancer progression, and will contribute to his further efforts towardsthe improvement of cancer diagnosis and treatment. He shares the prize with French scientist Jerome Galon.  

18 - 1 -2021

A growing success story 

KU Leuven interviews Hans Clevers (Hubrecht Insitute) in depth about how he, together with his team, developed a way to grow organoids – lab-made miniature versions of our organs .  

9 - 12 - 2020

Not one, but two ERC grants! 

Puck Knipscheer and Jop Kind (both Hubrecht Institute) individually receive a prestigious European Research Council (ERC) Consolidator Grant! They are each given two million euros to strengthen their research groups and continue their innovative research for the next 5 years. 

11 - 11 - 20 

Tracking the cause of cancer 

Those who are sick want to know why. Ruben van Boxtel (PMC) addresses the big question of how cancer develops and explains how to use DNA to examine the origin of a tumor during a live lecture on Youtube.

Outsmarting cancer

impacting lives


Outsmarting cancer

impacting lives